{"id":"W2510369693","doi":"10.1200/jco.2014.32.4_suppl.431","title":"A single-arm, phase II, multicenter trial of sunitinib maleate (SU) in locally advanced or metastatic pheochromocytoma/paraganglioma (PC/PG): Interim results.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Adrenal and Paraganglionic Tumors","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Centre Hospitalier de l’Université de Montréal; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Adverse effect; Clinical trial; Progressive disease; Interim analysis; Sunitinib; Radiological weapon; Phases of clinical research; Toxicity; Gastroenterology; Oncology; Surgery; Urology; Disease; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.005863182,0.0002984862,0.002972066,0.0004300708,0.00004292687,0.00001054482,0.0003417853,0.0003147777,0.0003923514],"category_scores_gemma":[0.01809329,0.000194109,0.0007194389,0.0004352089,0.000485745,0.0001918792,0.0001258002,0.001264688,0.00002173726],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001382211,"about_ca_system_score_gemma":0.001164728,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001546745,"about_ca_topic_score_gemma":0.000102503,"domain_scores_codex":[0.9914579,0.001307003,0.005870671,0.0003474308,0.0005580007,0.000459005],"domain_scores_gemma":[0.9897346,0.004973486,0.00375052,0.0003609264,0.0006372764,0.0005431385],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7598795,0.02694882,0.00004833649,0.0000973369,0.0003552411,0.03480695,0.0004107025,0.00005383015,0.0005821185,0.00007051168,0.0007829495,0.1759637],"study_design_scores_gemma":[0.6237313,0.334741,0.0009349998,0.001113518,0.0007342895,0.01222309,0.0004117812,0.001274956,0.003539287,0.0002964469,0.02071901,0.0002803541],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9911523,0.000119147,0.0007634792,0.002803913,0.001605357,0.0006302867,0.00002025131,0.00001631421,0.002888948],"genre_scores_gemma":[0.9902875,0.00003551166,0.006456719,0.001544325,0.001029624,0.000009139269,0.00001234551,0.00003350741,0.0005912961],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3077921,"threshold_uncertainty_score":0.9901778,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1806552080758155,"score_gpt":0.4902337475234008,"score_spread":0.3095785394475853,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}